Related Experiment Video
Updated: Aug 4, 2026

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
Published on: March 6, 2018
High-affinity renal lead-binding proteins in environmentally-exposed humans
D R Smith1, M W Kahng, B Quintanilla-Vega
1Biology and Environmental Toxicology, University of California, Santa Cruz 95064, USA. dsmith@biology.ucsc.edu
Chronic low-level lead exposure harms kidney function. Researchers identified thymosin beta 4 and acyl-CoA binding protein as key lead-binding proteins in human kidneys, revealing new toxicity mechanisms.
Area of Science:
- Toxicology
- Molecular Biology
- Environmental Health
Background:
- Chronic low-level lead (Pb) exposure is linked to reduced kidney function in humans.
- The precise molecular mechanisms driving lead toxicity remain largely unknown.
Purpose of the Study:
- To identify specific cytosolic lead-binding proteins (PbBPs) in the kidneys of environmentally exposed humans.
- To elucidate the molecular targets of lead and understand its toxicity mechanisms in renal tissue.
Main Methods:
- Investigated cytosolic PbBPs in kidney cortex tissue from environmentally exposed humans.
- Localized PbBPs based on physiologically bound lead in vivo.
- Identified and characterized lead-binding polypeptides using biochemical methods.
Main Results:
- Identified two high-affinity lead-binding polypeptides: thymosin beta 4 (Tβ4) and acyl-CoA binding protein (ACBP/DBI).
- These proteins bind lead with high affinity (Kd ≈ 14 nM) and constitute over 35% of total kidney cortex lead.
- Tβ4 and ACBP/DBI are conserved across species and tissues, involved in diverse cellular functions.
Conclusions:
- Provides the first evidence of specific molecular targets for lead in human kidney tissue.
- Suggests that low-level lead toxicity may result from altered functions of Tβ4 and ACBP/DBI in renal and other tissues, including the central nervous system.
More Related Videos
08:46Dose Uptake of Platinum- and Ruthenium-based Compound Exposure in Zebrafish by Inductively Coupled Plasma Mass Spectrometry with Broader Applications
Published on: April 21, 2022
06:32Development of Human Renal Tubular Epithelial Cell Primary Cultures in Monolayers and Three-Dimensional Conditions
Published on: June 13, 2025
Related Concept Videos
Drug Distribution: Tissue Binding
For...
Drug Distribution: Plasma Protein Binding
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Renal Drug Excretion: Tubular Reabsorption
Renal Drug Excretion: Tubular Secretion
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted less...